Drug-induced side effects may complicate the picture in severely sick patients in the intensive care unit (ICU) treated with multiple drugs and with several affected organ systems. Presented here is a case where prolonged hyperthermia was suspected to be induced by intravenously administered furosemide.
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An 18-year-old girl suffered from verified severe Mycoplasma pneumoniae infection with complicating pulmonary hypertension, pronounced cryoglobulinaemia and rhabdomyolysis. The patient was mechanically ventilated, sedated and required haemodialysis for several weeks at the ICU.
At the age of 2 weeks the patient had had surgical treatment of congenital aortic coarctation. She had an asymptomatic mitral stenosis and received no medication.
The Mycoplasma infection was treated successfully with intravenous clarithromycin supplemented with meropenem. By day 19, the temperature and C-reactive protein (CRP) ( Fig. 1) had normalised, and the cryoglobulins had disappeared by day 27.
At day 24 the patient developed a second episode of hyperthermia ( Fig. 1) , without a concurrent increase in CRP. Simultaneously, the patient developed dermal blisters, histologically described as oedema with modest lymphocytic inflammation without eosinophilia. The patient was persistently hyperthermic and exhaustive investigation failed to detect ongoing infection.
During this hyperthermia period, the patient was continuously infused with furosemide, remifentanil and actrapid. Moreover, treatment consisted of meropenem and methylprednisolone (iv), esomeprazole and paracetamol, and dalteparin (Fig. 1) . To exclude drug-induced side effects, furosemide, dalteparin and esomeprazole were discontinued on day 29. Within 2 days the temperature and heart rate declined, and the skin manifestations vanished.
The patient was rechallenged with two doses of furosemide 5 mg iv on day 32, which triggered an almost simultaneous increase in heart rate and temperature (Fig. 1 inset) and caused the blisters to reappear. After discontinuation of furosemide, all three symptoms quickly faded.
Meropenem, esomeprazole and dalteparin were reintroduced later and were all well-tolerated.
In conclusion, furosemide is suspected of causing hyperthermia. Neither the European (EMEA) nor the Danish Medicines Agency has issued any reports of furosemide-induced hyperthermia in adolescents, and the literature is sparse [1] [2] [3] . Drug-induced fever is a serious morbidity that may prompt exhaustive evaluation and cause prolonged hospitalisation. Fig. 1 C-reactive protein  (CRP) , temperature, medication and heart rate during ICU admittance. Plasma CRP was measured daily. Temperature (intravasal) and heart rate were registered automatically every 5 min (Scoop Siemens SC 9000XL). Furosemid (Nycomed), remifentanyl and actrapid were continously infused. Meropenem, methylparacetamol (1 g × 4) and esomeprazole were administered daily via the nasogastric tube
